4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-042246
CEO sold 71,602 shares at an average $25.04 ($1,792,899)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-07-11 | Sale 10b5-1 | −16,498 | $25.00 | $412,450 | 91,799 | D |
| DAVIS STEPHEN CEO | 2023-07-12 | Sale 10b5-1 | −55,104 | $25.05 | $1,380,449 | 36,695 | D |
| Open-market sales · 71,602 sh · avg $25.04 · $1,792,899 | |||||||
Loading xslF345X04/doc4.xml…